1. Home
  2. CVKD vs GAME Comparison

CVKD vs GAME Comparison

Compare CVKD & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • GAME
  • Stock Information
  • Founded
  • CVKD 2022
  • GAME 2011
  • Country
  • CVKD United States
  • GAME United States
  • Employees
  • CVKD N/A
  • GAME N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • GAME
  • Sector
  • CVKD Health Care
  • GAME
  • Exchange
  • CVKD Nasdaq
  • GAME Nasdaq
  • Market Cap
  • CVKD 29.5M
  • GAME 27.2M
  • IPO Year
  • CVKD 2023
  • GAME 2009
  • Fundamental
  • Price
  • CVKD $12.90
  • GAME $2.22
  • Analyst Decision
  • CVKD Strong Buy
  • GAME Strong Buy
  • Analyst Count
  • CVKD 1
  • GAME 3
  • Target Price
  • CVKD $32.00
  • GAME $3.67
  • AVG Volume (30 Days)
  • CVKD 34.8K
  • GAME 6.1M
  • Earning Date
  • CVKD 08-06-2025
  • GAME 08-13-2025
  • Dividend Yield
  • CVKD N/A
  • GAME N/A
  • EPS Growth
  • CVKD N/A
  • GAME N/A
  • EPS
  • CVKD N/A
  • GAME N/A
  • Revenue
  • CVKD N/A
  • GAME $99,579,536.00
  • Revenue This Year
  • CVKD N/A
  • GAME $6.08
  • Revenue Next Year
  • CVKD N/A
  • GAME $21.94
  • P/E Ratio
  • CVKD N/A
  • GAME N/A
  • Revenue Growth
  • CVKD N/A
  • GAME 77.06
  • 52 Week Low
  • CVKD $5.70
  • GAME $0.50
  • 52 Week High
  • CVKD $22.90
  • GAME $2.87
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 49.22
  • GAME 92.95
  • Support Level
  • CVKD $11.00
  • GAME $0.73
  • Resistance Level
  • CVKD $13.56
  • GAME $0.97
  • Average True Range (ATR)
  • CVKD 1.13
  • GAME 0.18
  • MACD
  • CVKD 0.23
  • GAME 0.16
  • Stochastic Oscillator
  • CVKD 78.32
  • GAME 99.53

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.

Share on Social Networks: